Abstract
Introduction To learn the trajectories of cognitive function before and after stroke among Chinese participants.
Method During the seven-year follow-up, 401 participants survived incident stroke and 7551 remained stroke free. Cognitive function was assessed by a global cognition score, which included episodic memory, visuospatial abilities, and executive function. A linear mixed model was developed to explore the repeated measurements.
Result There was no significant difference between the rate of pre-stroke cognitive decline and the decline rate of cognition among stroke-free participants. Among the stroke survivors, the acute decline was -0.123 and -0.187 SD/y in cognitive domains of episodic memory and visuospatial ability, respectively. Executive function did not decline acutely after stroke. In the years after stroke, the decline rate of global cognition was 0.074 SD/y faster than the rate before stroke. The additional decline rate of episodic memory and executive function was 0.043 and 0.061 SD/y, respectively. The rate of visuospatial ability did not change after stroke.
Conclusion Among Chinese stroke survivors, incident stroke was associated with acute decline in episodic memory and visuospatial abilities, and accelerated decline in episodic memory, orientation, attention, and calculation. Cognitive training may help alleviate post-stroke cognitive impairment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Natural Science Foundation of China (project number 81973143) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for all the CHARLS waves was granted from the Institutional Review Board at Peking University. The IRB approval number for the main household survey, including anthropometrics, is IRB00001052-11015; the IRB approval number for biomarker collection is IRB00001052-11014. During the fieldwork, each respondent who agreed to participate in the survey was asked to sign two copies of informed consent; one copy was kept in the CHARLS office, which was also scanned and saved in PDF format. Four separate consents were obtained: one for the main fieldwork, one for the non-blood biomarkers and one for the taking of the blood samples, and another for storage of blood for future analyses.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos